Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

2.18
+0.16007.92%
Post-market: 2.190.0100+0.46%19:59 EST
Volume:4.70M
Turnover:10.32M
Market Cap:457.09M
PE:-1.42
High:2.32
Open:2.05
Low:2.04
Close:2.02
Loading ...
Jul 22, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 24, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 24, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 24, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 24, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Major Issues Report

Current report, item 5.07
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 15, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
May 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 05, 2018

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Oct 04, 2018

Correspondence

[Cover]Correspondence
Oct 04, 2018

Correspondence

[Cover]Correspondence